Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by lscfaon May 29, 2024 10:04am
64 Views
Post# 36062130

RE:New Press Release - Ceapro Inc. Reports Financial Results for First Quarter 2024 and Provides Corporate Update

RE:New Press Release - Ceapro Inc. Reports Financial Results for First Quarter 2024 and Provides Corporate UpdateDrunken sailor spending....


 

 

Revenues

Gross profit

Gross margin

Cash flow ops

R&D

G&A incl legal

Legal fees

Q1 24

2,773,788

1,218,406

43.9%

(1,913,091)

1,432,824

2,229,528

920,000

Q4 23

1,650,858

200,058

12.1%

(2,078,573)

666,346

2,300,198

1,051,000

Q3 23

2,618,973

1,080,023

41.2%

(761,591)

584,665

1,972,884

921,000

Q2 23

1,868,758

1,070,270

57.3%

(893,302)

926,775

1,625,066

232,000

Q1 23

3,494,811

1,605,838

45.9%

162,738

573,687

1,521,445

343,000

 


<< Previous
Bullboard Posts
Next >>